𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Investigation into the immunological effects of miltefosine, a new anticancer agent under development

✍ Scribed by P. Hilgard; E. Kampherm; L. Nolan; J. Pohl; T. Reissmann


Book ID
112574017
Publisher
Springer-Verlag
Year
1991
Tongue
English
Weight
769 KB
Volume
117
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pharmaceutical development of a lyophili
✍ Monique W.J. Den Brok; Bastiaan Nuijen; Christiane Lutz; Hans-Georg Opitz; Jos H πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 167 KB

Imexon is a member of the class of 2-cyanoaziridine derivatives, which have been of interest as immunomodulators and anticancer agents since the late 1970s. For the scheduled phase I clinical trials a stable, sterile, injectable pharmaceutical dosage form containing 100 mg Imexon was required. Despi